Genome-wide association study identifies a common variant associated with risk of endometrial cancer
- PMID: 21499250
- PMCID: PMC3770523
- DOI: 10.1038/ng.812
Genome-wide association study identifies a common variant associated with risk of endometrial cancer
Abstract
Endometrial cancer is the most common malignancy of the female genital tract in developed countries. To identify genetic variants associated with endometrial cancer risk, we performed a genome-wide association study involving 1,265 individuals with endometrial cancer (cases) from Australia and the UK and 5,190 controls from the Wellcome Trust Case Control Consortium. We compared genotype frequencies in cases and controls for 519,655 SNPs. Forty seven SNPs that showed evidence of association with endometrial cancer in stage 1 were genotyped in 3,957 additional cases and 6,886 controls. We identified an endometrial cancer susceptibility locus close to HNF1B at 17q12 (rs4430796, P = 7.1 × 10(-10)) that is also associated with risk of prostate cancer and is inversely associated with risk of type 2 diabetes.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
References
-
- Ferlay J, et al. IARC, editor. CancerBase No. 10 [Internet] Vol. 2010. International Agency for Research on Cancer Lyon; France: 2010. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide.
-
- Varol N, et al. Ten-year review of hysterectomy morbidity and mortality: can we change direction? Aust N Z J Obstet Gynaecol. 2001;41:295–302. - PubMed
-
- Hindorff LA, Junkins HA, Hall PN, Mehta JP, Manolio TA. A Catalog of Published Genome-Wide Association Studies. National Human Genome Research Institute; 2010.
-
- Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst. 1994;86:1600–8. - PubMed
-
- Hemminki K, Vaittinen P, Kyyronen P. Age-specific familial risks in common cancers of the offspring. Int J Cancer. 1998;78:172–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA64277/CA/NCI NIH HHS/United States
- 11022/CRUK_/Cancer Research UK/United Kingdom
- R01 CA092585/CA/NCI NIH HHS/United States
- R01 CA090899/CA/NCI NIH HHS/United States
- R01 CA064277/CA/NCI NIH HHS/United States
- 090532/WT_/Wellcome Trust/United Kingdom
- R01 CA 092585/CA/NCI NIH HHS/United States
- 10118/CRUK_/Cancer Research UK/United Kingdom
- C1287/A10118/CRUK_/Cancer Research UK/United Kingdom
- A10124/CRUK_/Cancer Research UK/United Kingdom
- 10124/CRUK_/Cancer Research UK/United Kingdom
- C8197/A10123/CRUK_/Cancer Research UK/United Kingdom
- C490/A1021/CRUK_/Cancer Research UK/United Kingdom
- A10119/CRUK_/Cancer Research UK/United Kingdom
- C490/A10124/CRUK_/Cancer Research UK/United Kingdom
- R01 CA90899/CA/NCI NIH HHS/United States
- 11021/CRUK_/Cancer Research UK/United Kingdom
- 10119/CRUK_/Cancer Research UK/United Kingdom
- C8197/A10865/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
